Related references
Note: Only part of the references are listed.Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity
Laurel T. Bate-Eya et al.
EUROPEAN JOURNAL OF CANCER (2017)
WikiPathways: capturing the full diversity of pathway knowledge
Martina Kutmon et al.
NUCLEIC ACIDS RESEARCH (2016)
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
Etienne Dardenne et al.
CANCER CELL (2016)
Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable Neuroblastomas
Kai-Oliver Henrich et al.
CANCER RESEARCH (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer et al.
NATURE (2015)
Mutational dynamics between primary and relapse neuroblastomas
Alexander Schramm et al.
NATURE GENETICS (2015)
RASSF1A methylation may have two biological roles in neuroblastoma tumorigenesis depending on the ploidy status and age of patients
Masayuki Haruta et al.
CANCER LETTERS (2014)
Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
Sarah K. Knutson et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
Eunhee Kim et al.
CANCER CELL (2013)
Selective HDAC1/HDAC2 Inhibitors Induce Neuroblastoma Differentiation
Stacey M. Frumm et al.
CHEMISTRY & BIOLOGY (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR
Chunxi Wang et al.
CANCER RESEARCH (2012)
Prognostic Significance of Promoter DNA Methylation in Patients with Childhood Neuroblastoma
Diana T. Lau et al.
CLINICAL CANCER RESEARCH (2012)
PRC2 directly methylates GATA4 and represses its transcriptional activity
Aibin He et al.
GENES & DEVELOPMENT (2012)
Molecular and genetic bases of neuroblastoma
Takehiko Kamijo et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
Sarah K. Knutson et al.
NATURE CHEMICAL BIOLOGY (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
A SP1/MIZ1/MYCN Repression Complex Recruits HDAC1 at the TRKA and p75NTR Promoters and Affects Neuroblastoma Malignancy by Inhibiting the Cell Response to NGF
Nunzio Iraci et al.
CANCER RESEARCH (2011)
MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas
Ruimin Huang et al.
FASEB JOURNAL (2011)
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
Shuet Theng Lee et al.
MOLECULAR CELL (2011)
Prognostic Impact of MYCN, DDX1, TrkA, and TrkC Gene Transcripts Expression in Neuroblastoma
Daniela Raguer Valadao de Souza et al.
PEDIATRIC BLOOD & CANCER (2011)
Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
Martin Sauvageau et al.
CELL STEM CELL (2010)
Deregulation of H3K27 methylation in cancer
Eva Martinez-Garcia et al.
NATURE GENETICS (2010)
Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bβ and TSLC1 in neuroblastoma
H. Ochiai et al.
ONCOGENE (2010)
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
Joelel Vermeulen et al.
LANCET ONCOLOGY (2009)
Stress via p53 pathway causes apoptosis by mitochondrial Noxa upregulation in doxorubicin-treated neuroblastoma cells
K. Kurata et al.
ONCOGENE (2008)
Promoter hypermethylation of the RASSF1A gene predicts the poor outcome of patients with hepatoblastoma
Waka Sugawara et al.
PEDIATRIC BLOOD & CANCER (2007)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas
Masanobu Abe et al.
CANCER LETTERS (2007)
Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma
H. Niizuma et al.
ONCOGENE (2006)
Distinct roles of Polycomb group gene products in transcriptionally repressed and active domains of Hoxb8
Yu-ichi Fujimura et al.
DEVELOPMENT (2006)
Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas
M Ohira et al.
CANCER CELL (2005)
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma
A Tacconelli et al.
CANCER CELL (2004)
Production of monoclonal antibodies against mammalian Ring1B proteins
T Atsuta et al.
HYBRIDOMA (2001)
Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
T Teitz et al.
NATURE MEDICINE (2000)
Share Paper
